老年女性晚期乳腺癌卡培他滨节律化疗的临床疗效(3)
 |
| 第1页 |
参见附件。
[4]曹文明，陈占红，楼彩金，等.卡培他滨单药与联合化疗治疗老年女性晚期乳腺癌的临床研究[J].中国肿瘤，2008,17(9)：821-824.
[5]Enrique LA,Ana Carolina SV,Yadira BC,et al.Phase II study of metronomic chemotherapy with thalidomide,carbop latin-vincristine-fluvastatin in the treatment of brain stem tumors in children[J].Archiv Med Res,2008,39(7):655-662.
[6]Caballero M,Grau J,Palmero R,et al.Serum vascular endothelial growth factor as prognostic factor in metronomic weekly paclitaxel treatment for patients with advanced head and neck cancer refractory to platinum-based chemotherapy[J].Radiotherapy Oncology,2007,82(3):33.
[7]陈文，谈景东，荣维国，等.68例Ⅱ~Ⅲ期乳腺癌新辅助化疗的回顾性分析[J].中国医学创新，2010，7(22)：70-71.
[8]Steinbild S,Arends J,Mediger M,et al.Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tum or patients-results of a phase II study [J].Onkologie,2007,30(12):629-635.
[9]Fedele P,Marino A,Orlando L,et al.Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer[J].European Journal of Cancer,2001,48(1):24-29.
【收稿日期】2011-10-24
您现在查看是摘要介绍页，详见PDF附件。